Skip to main content
Anuh Pharma Ltd. logo

Anuh Pharma Ltd. — Investor Relations & Filings

Ticker · ANUHPHR ISIN · INE489G01022 LEI · 335800IVKUOYQSJUVH89 BSE.NS Manufacturing
Open in API
Filings indexed 620 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS ANUHPHR

About Anuh Pharma Ltd.

https://www.anuhpharma.com

Anuh Pharma Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, specializing in the production of Macrolides, including Erythromycin salts, Azithromycin, and Clarithromycin. Its product portfolio also encompasses Anti-TB agents such as Pyrazinamide and Ethambutol, Anti-malarials like Chloroquine Phosphate, and a range of Corticosteroids including Dexamethasone and Betamethasone. Operating with global quality standards, the company maintains certifications such as WHO-GMP, EU-GMP, and CEP. Anuh Pharma focuses on large-scale manufacturing and the supply of high-quality intermediates to pharmaceutical formulators worldwide. The organization leverages advanced chemical synthesis capabilities to serve diverse therapeutic segments, ensuring consistent supply chain reliability and regulatory compliance across international markets.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a compliance submission under SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 31(4), providing a yearly disclosure of shareholding by the promoter and promoter group. It is not an earnings report, board change, call transcript, or financial report type; rather it is a routine regulatory filing/disclosure to stock exchanges. This falls under the general regulatory announcements and compliance filings category.
2026-05-26 English
Updates
Major Shareholding Notification Classification · 85% confidence The document is an intimation under SEBI (LODR) Regulations 2015 notifying the stock exchanges of shareholding reclassification of certain persons from the Promoter Group to the Public category, detailing their shareholdings. This is a notification of changes in significant share ownership levels, matching the definition of Major Shareholding Notification (MRQ).
2026-05-25 English
Intimation for filing of the application for reclassification of shareholders from Promoter Group to Public Category
Major Shareholding Notification Classification · 72% confidence The document is an official stock exchange intimation under SEBI LODR Regulation 31A(8)(c) notifying reclassification of certain persons from the promoter group to the public category and listing their equity shareholdings. This is a formal change in shareholding classification, fitting the definition of a Major Shareholding Notification (MRQ).
2026-05-25 English
Updates
Regulatory Filings Classification · 85% confidence The document is an official intimation sent to the stock exchanges under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the re-classification of certain shareholders from the “Promoter Group” to “Public” category. It is a compliance announcement rather than a full financial report, earnings release, management change notice, or share issuance. It does not contain substantive financial statements or qualify as an annual/interim report, and it is not a director dealing or dividend notice. Therefore, it best fits the fallback category for general regulatory announcements under “Regulatory Filings” (RNS).
2026-05-22 English
Intimation for the Resolution for reclassification of shareholders from Promoter group to Public category
Regulatory Filings Classification · 90% confidence The document is an intimation under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations providing a certified true copy of a Board resolution approving the re-classification of certain shareholders from the promoter group to public category. It is a regulatory compliance announcement to stock exchanges rather than a financial report or capital raising document. It does not involve share issuance, dividend notice, management change, or earnings data. It falls under general regulatory filings.
2026-05-22 English
Newspaper Publication of the Audited financial results for the Quarter and Year ended 31st March, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi ....
Regulatory Filings
2026-05-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.